Does USTEKINUMAB Cause Therapeutic product effect incomplete? 1,073 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,073 reports of Therapeutic product effect incomplete have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 1.3% of all adverse event reports for USTEKINUMAB.
1,073
Reports of Therapeutic product effect incomplete with USTEKINUMAB
1.3%
of all USTEKINUMAB reports
370
Deaths
551
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From USTEKINUMAB?
Of the 1,073 reports, 370 (34.5%) resulted in death, 551 (51.4%) required hospitalization, and 353 (32.9%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 1,073 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which USTEKINUMAB Alternatives Have Lower Therapeutic product effect incomplete Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE